Publications by authors named "G Vanden Bergh"

Recent discoveries of Homo floresiensis and H. luzonensis raise questions regarding how extreme body size reduction occurred in some extinct Homo species in insular environments. Previous investigations at Mata Menge, Flores Island, Indonesia, suggested that the early Middle Pleistocene ancestors of H.

View Article and Find Full Text PDF

Background And Objectives: Older adults residing in residential aged care facilities (RACFs) often experience substandard transitions to emergency departments (EDs) through rationed and delayed ED care. We aimed to identify research describing interventions to improve transitions from RACFs to EDs.

Research Design And Methods: In our scoping review, we included English language articles that (a) examined an intervention to improve transitions from RACF to EDs; and (b) focused on older adults (≥65 years).

View Article and Find Full Text PDF

Introduction: Tungiasis is a painful skin infection caused by a flea called Tunga Penetrans/jiggers, which enters the epidermis of humans and animals. If untreated it may result in bacterial infection, sepsis, necrosis, and disability. In Kenya, it is estimated that 4% of the population suffer from jigger infestation.

View Article and Find Full Text PDF

Background: Cardiovascular disease remains the leading cause of death in chronic kidney disease (CKD) patients, especially in those undergoing dialysis and kidney transplant surgery. CKD patients are at high risk of developing arterial media calcifications (AMC) and arterial stiffness. We hypothesized that investigation of disease progression at an early stage could provide novel insights in understanding AMC etiology.

View Article and Find Full Text PDF
Article Synopsis
  • - This study analyzed real-world data from CRPC patients to assess how common visceral metastases (VMs) are and how they affect patient survival, using data from the CAPRI registry over several years.
  • - Out of 3602 patients, 12.7% were diagnosed with VMs, with varying survival rates based on the type of metastases: median survival was 8.6 months for liver, 18.3 months for lung, and 10.9 months for both types.
  • - Despite a rising trend in screening for VMs as treatment progresses, a significant number of patients (80% at diagnosis to 40% by the sixth treatment line) were still not screened, highlighting the importance of
View Article and Find Full Text PDF